SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-21-015671
Filing Date
2021-03-26
Accepted
2021-03-26 08:31:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A evok-defa14a_20210505.htm DEFA14A 31468
2 GRAPHIC g52q203p3gpz000001.jpg GRAPHIC 642635
3 GRAPHIC g52q203p3gpz000002.jpg GRAPHIC 233469
  Complete submission text file 0001564590-21-015671.txt   1239082
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36075 | Film No.: 21774804
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences